Proteomics for understanding progression to heart failure in chronic kidney disease: promising but still not there

Autores da FMUP

• João Pedro Melo Marques Pinho Ferreira

  Autor

Participantes de fora da FMUP

• Zannad F.

Unidades de investigação

• Cirurgia e Fisiologia

• Laboratório Associado RISE- Rede de Investigação em Saúde

  

  Investigador

  Fernando Carlos De Landér Schmitt

Abstract

[No abstract available]

Keywords

• Biomarkers; Disease Progression; Heart Failure; Humans; Kidney Failure, Chronic; Proteomics; Renal Insufficiency, Chronic; amino terminal pro brain natriuretic peptide; aptamer; asialoglycoprotein; biological marker; carbonate dehydratase; glucagon like peptide 1; sodium glucose cotransporter 2 inhibitor; somatomedin binding protein 3; troponin T; biological marker; albuminuria; atherosclerosis; blood pressure; cardiovascular disease; chronic kidney failure; disease exacerbation; editorial; Editorial; estimated glomerular filtration rate; extracellular matrix; heart failure; heart failure with reduced ejection fraction; heart left ventricle ejection fraction; human; hypertension; major clinical study; Mendelian randomization analysis; obesity; oxidative stress; phenotype; proteomics; quality control; risk factor; blood; chronic kidney failure; complication; metabolism